Stockscreener 앱 받기
206.60
2.23%
-4.72
시간 외 거래:
206.65
0.05
+0.02%
Abbvie Inc 주식(ABBV)의 최신 뉴스
AbbVie (NYSE:ABBV) Upgraded to Strong-Buy at DZ Bank - MarketBeat
Benjamin Edwards Inc. Has $77.83 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Artemis Investment Management LLP Has $160.86 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie (NYSE:ABBV) Updates Q2 2026 Earnings Guidance - MarketBeat
AbbVie (NYSE:ABBV) Stock Price Down 2.2%Here's What Happened - MarketBeat
AbbVie Inc. stock underperforms Friday when compared to competitors - MarketWatch
AbbVie’s Earnings Beat Wall Street’s Estimates. Investors Are Still Worried - WSJ
ABBV Reiterated by Guggenheim -- Price Target Maintained at $249 - GuruFocus
10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga
AbbVie (NYSE: ABBV) Posts Q1 Revenue of $15B, Raises Guidance - Value The Markets
AbbVie Stock Beats Q1 Estimates as Skyrizi Hits $4.5B in a Single Quarter - TIKR.com
AbbVie option and FDA feedback reshape Aldeyra (Nasdaq: ALDX) drug plans - Stock Titan
Oppenheimer & Co. Inc. Sells 8,094 Shares of AbbVie Inc. $ABBV - MarketBeat
Fifth Third Bancorp Grows Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Danske Bank A S Has $267.24 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. (ABBV) One of the Best Drug Stocks to Buy According to Analysts? - Yahoo Finance
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2026 - GlobeNewswire Inc.
FDA filing for investigational alopecia areata treatment lifts AbbVie stock 3.65% - Traders Union
AbbVie stock jumps 3.65% as Q1 2026 earnings call announcement boosts sentiment - Traders Union
Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT - Insider Monkey
AbbVie Inc (ABBV) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 86/100 - GuruFocus
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec - Investing News Network
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
AbbVie: Balancing Potential Acquisition Impact With Positive Q1 2026 Earnings (NYSE:ABBV) - Seeking Alpha
AbbVie and adMare BioInnovations Award RIME Therapeutics to Advance Biotech Innovation in Quebec - Quiver Quantitative
ABBV Maintained by Morgan Stanley -- Price Target Raised to $278 - GuruFocus
Federated Hermes MDT Market Neutral ETF's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Q1 earnings loom: Buy or sell the stock ahead of results? - MSN
AbbVie Expected to Post Durable Growth Into Mid-2030s, BofA Securities Says - marketscreener.com
New York State Teachers Retirement System Sells 39,154 Shares of AbbVie Inc. $ABBV - MarketBeat
ABBV Reiterates by Cantor Fitzgerald -- Price Target Maintained at $240 - GuruFocus
Price Prediction: Why AbbVie’s Post-Humira Pivot Makes It a Strong Buy - Yahoo Finance
AbbVie Stock Forecast: Trending Buy Calls From Analysts - TipRanks
ABBV shares surge with Skyrizi and Rinvoq sales offsetting Humira decline: weekly forecast - Traders Union
AbbVie Inc Stock (ABBV) Moved Up by 3.49% on Apr 30: A Full Analysis - TradingKey
Jennison Associates LLC Has $271.21 Million Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
US Bancorp DE Sells 41,982 Shares of AbbVie Inc. $ABBV - MarketBeat
Every new Allē referral sign-up sends $10 to Skin Cancer Foundation - Stock Titan
Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month - AbbVie News Center
AbbVie Inc. (NYSE:ABBV) Q1 2026 Earnings Call Transcript - Insider Monkey
Canaccord raises Abbvie stock price target on strong quarter - Investing.com
Lilly CEO shades amylin rivals AbbVie, Pfizer in cutthroat battle for obesity’s next act - BioSpace
Sarofim Equity Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
BofA upgrades Abbvie stock rating on immunology strength - Investing.com
Invesco Charter Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie upgraded to Buy at BofA on durable growth - TipRanks
Goldman Sachs raises Abbvie stock price target on growth confidence - Investing.com
AbbVie Stock (US00287Y1091): Reports Strong Q1 2026 Results with EPS Beat - AD HOC NEWS
Goldman Sachs Enhanced U.S. Equity ETF's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie Inc (ABBV) Q1 2026 Earnings Call Highlights: Strong Reven - GuruFocus
AbbVie Q1 Earnings Call Highlights - Yahoo Finance
U.S. Large Cap Growth Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie stock price forecast: consolidation likely as ABBV struggles beneath key resistance - Traders Union
AbbVie stock price forecast: seller pressure persists as ABBV stalls below moving averages despite weekly gain - Traders Union
AbbVie (ABBV) Reports Strong Q1 2026 Results and Raises Full-Yea - GuruFocus
AbbVie Inc (ABBV) Shares Surge 3.1% -- What GF Score of 85 Tells Investors - GuruFocus
Pharma Q1 2026, AbbVie AstraZeneca Teva Beat Estimates - Gotrade
Howard Hughes Medical Institute's AbbVie Inc(ABBV) Holding History - GuruFocus
Vanguard (ABBV) holds 132.9M shares, a 7.51% stake in AbbVie - Stock Titan
AbbVie Earnings: Immunology Portfolio and Pipeline Look Solid - Morningstar
AbbVie (ABBV) Stock Trades Up, Here Is Why - TradingView
AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? - MarketBeat
AbbVie Thanks 'Excellent Start To 2026' To Immunology And Neuroscience StrengthAbbVie (NYSE:ABBV) - Benzinga
AbbVie Beats Earnings Estimates, Boosts 2026 Outlook. What It Means for the Stock. - Barron's
AbbVie tops Q1 estimates, raises outlook and discontinues cancer candidate - BioSpace
AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit - Law360
Research Alert: CFRA Retains Buy Rating On Shares Of Abbvie Inc. - 富途牛牛
AbbVie Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View - The Globe and Mail
AbbVie Inc. (ABBV.US) 1Q EPS Beats; Raises FY2026 Outlook - AASTOCKS.com
1.40%
2.73%
자본화:
|
볼륨(24시간):